s6y

Altimmune, Inc.

Ticker
ALT
CIK
1326190
Industry
Pharmaceutical Preparations
Formerly
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP

Financials 95

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K Annual Report for period ending Dec 31, 2025
  5. 10-Q Quarterly Report for period ending Sep 30, 2025
  6. 10-Q Quarterly Report for period ending Jun 30, 2025
  7. 10-Q Quarterly Report for period ending Mar 31, 2025
  8. 10-K Annual Report for period ending Dec 31, 2024
  9. 10-Q Quarterly Report for period ending Sep 30, 2024
  10. 10-Q Quarterly Report for period ending Jun 30, 2024

All 95 financials filings

News 289

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 289 news filings

Ownership 812

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 3 Initial statement of beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 3 Initial statement of beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 812 ownership filings

Prospectus 102

  1. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  2. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  3. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  4. S-3MEF A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-3
  5. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  6. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  7. S-3/A Registration statement for specified transactions by certain issuers
  8. S-3 Registration statement for specified transactions by certain issuers
  9. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  10. S-3 Registration statement for specified transactions by certain issuers

All 102 prospectus filings

Proxies 47

  1. DEF 14A Definitive proxy statements
  2. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  3. DEF 14A Definitive proxy statements
  4. DEF 14A Definitive proxy statements
  5. DEF 14A Definitive proxy statements
  6. DEF 14A Definitive proxy statements
  7. DEF 14A Definitive proxy statements
  8. DEF 14A Definitive proxy statements
  9. DEF 14A Definitive proxy statements
  10. PRER14A Preliminary revised proxy soliciting materials

All 47 proxies filings

Other 128

  1. SCHEDULE 13G/A
  2. SCHEDULE 13G
  3. SCHEDULE 13G/A
  4. SCHEDULE 13G
  5. SCHEDULE 13G
  6. SCHEDULE 13G
  7. SCHEDULE 13G
  8. SCHEDULE 13G
  9. SCHEDULE 13G/A
  10. ARS Annual report to security holders

All 128 other filings